Old Web
English
Sign In
Acemap
>
Paper
>
PCN120 HEALTHCARE COSTS IN WOMEN WITH HR+/HER2- METASTATIC BREAST CANCER TREATED WITH CDK4/6 INHIBITORS
PCN120 HEALTHCARE COSTS IN WOMEN WITH HR+/HER2- METASTATIC BREAST CANCER TREATED WITH CDK4/6 INHIBITORS
2020
R. Burne
S Balu
A. Guérin
Y. Liang
R. Schloessmann
R Bungay
M.L. Paul
Keywords:
Intensive care medicine
Health care
Medicine
Metastatic breast cancer
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]